The FTC mandates Illumina dissolve its relationship with Grail
POLITICO's Pulse Check - Un podcast de POLITICO
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States. Learn more about your ad choices. Visit megaphone.fm/adchoices
